**Core Concept**
Chemotherapy-induced cardiotoxicity is a well-documented side effect of certain chemotherapeutic agents, particularly anthracyclines and trastuzumab. This phenomenon is characterized by the direct or indirect damage to cardiac myocytes, leading to impaired cardiac function and potentially life-threatening complications.

**Why the Correct Answer is Right**
Anthracyclines, such as doxorubicin, exert their cardiotoxic effects through the generation of reactive oxygen species (ROS) and the disruption of the mitochondrial electron transport chain. This results in the activation of various pro-apoptotic pathways, ultimately leading to the death of cardiac myocytes. The cardiotoxic effects of anthracyclines can be exacerbated by factors such as high doses, rapid infusion rates, and pre-existing cardiac disease.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is not directly related to chemotherapeutic cardiotoxicity. While certain chemotherapeutic agents can cause pulmonary toxicity, this is a distinct side effect that is not addressed by this option.
* **Option B:** This option is incorrect because it does not accurately describe the primary mechanism of chemotherapeutic cardiotoxicity. While certain chemotherapeutic agents can cause vascular damage, this is not the primary mechanism of cardiotoxicity.
* **Option C:** This option is incorrect because it is a general term that does not specifically relate to chemotherapeutic cardiotoxicity. While certain chemotherapeutic agents can cause various forms of organ damage, this option is too broad and does not accurately describe the specific phenomenon of chemotherapeutic cardiotoxicity.

**Clinical Pearl / High-Yield Fact**
It is essential for clinicians to be aware of the cardiotoxic potential of certain chemotherapeutic agents, particularly anthracyclines, and to take steps to mitigate this risk through the use of cardioprotective agents and careful monitoring of cardiac function.

**Correct Answer:** C.